Theravance Biopharma TBPH Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Theravance Biopharma’s reported figures.
Based on trailing twelve months.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's interest coverage?
- Theravance Biopharma (TBPH) reported interest coverage of -1.5× in Q4 2025.
- How has Theravance Biopharma's interest coverage changed year-over-year?
- Theravance Biopharma's interest coverage increased by 92.1% year-over-year, from -18.4× to -1.5×.
- What is the long-term trend for Theravance Biopharma's interest coverage?
- Over 4 years (2021 to 2025), Theravance Biopharma's interest coverage has grown at a -37.0% compound annual growth rate (CAGR), from -9.3× to -1.5×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.